Preeclampsia screening must now be covered by group health plans

The U.S. Preventive Services Task Force (Task Force) has published a final recommendation statement and evidence summary on screening for preeclampsia. The Task Force recommends screening pregnant women for preeclampsia with blood pressure measurements throughout pregnancy. This is a B recommendation, and, as such, non-grandfathered group health plans may not impose any cost-sharing requirements (such as a copayment, coinsurance, or a deductible) and must provide coverage with respect to preeclampsia screening (ERISA Reg. Sec. 2590.715-2713(a)(1)).
Preeclampsia is associated with high blood pressure in pregnant women after 20 weeks of pregnancy. It is one of the most serious health problems affecting pregnant women and is a leading cause of preterm delivery and low birth weight in the U.S.
This final recommendation applies to pregnant women without a current diagnosis of preeclampsia and with no signs or symptoms of preeclampsia or hypertension. It updates the 1996 final recommendation and is consistent with the 2016 draft recommendation.
This recommendation statement can be viewed on the Task Force Web site at: A draft version of the recommendation statement was available for public comment from September 27 to October 24, 2016. The Task Force is an independent, volunteer panel of national experts in prevention and evidence-based medicine that makes evidence-based recommendations about clinical preventive services such as screenings, counseling services, and preventive medications on behalf of the American people.
SOURCE: U.S. Preventive Services Task Force press release, April 25, 2017.
Visit our News Library to read more news stories.